查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1989009

生物聚合物创新市场预测至2034年：按聚合物类型、原料、应用和地区分類的全球分析

Biopolymer Innovation Market Forecasts to 2034 - Global Analysis By Polymer Type, Source, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，预计到 2026 年，全球生物聚合物创新市场规模将达到 26 亿美元，并在预测期内以 12.0% 的复合年增长率增长，到 2034 年将达到 65 亿美元。

生物聚合物创新领域正透过创造环保替代传统塑胶的材料，改变多个产业结构。科学家正利用植物、藻类和微生物等可再生资源生产高性能生物聚合物，确保其可生物降解并最大限度地减少对环境的影响。这些材料正被应用于包装、医疗、纺织和汽车等行业，以减少石化燃料的使用和碳排放。目前的研究重点在于提高生物聚合物的强度、耐热性和多功能性，以满足产业标准。此外，生物聚合物也被设计用于缓释製剂和可适应性材料等先进应用，从而在各个市场推动环境责任和技术进步。

根据欧洲生质塑胶协会的数据，全球生质塑胶（包括PLA、PHA、淀粉混合物和生物基PET等生物聚合物）产能预计将从2022年的约220万吨增加到2027年的约630万吨，主要受包装和消费品需求的推动。

包装产业需求不断成长

消费者对环保包装日益增长的需求是生物聚合物市场的主要驱动力。为了最大限度地减少对环境的负面影响，消费者正在寻求可生物降解和可再生包装方案。生物聚合物因其可堆肥且能保护内容物，正被越来越多地应用于食品容器、瓶子和包装材料。企业正在投资研发耐用、经济高效且具有阻隔性的生物聚合物。法规、政策和企业永续发展目标正在推动环保包装解决方案的普及。包装产业对环保材料的关注正在推动生物聚合物创新市场的发展，使其成为全球成长和在各工业领域广泛应用的关键因素。

高昂的生产成本

生物聚合物生产高成本，是限制市场成长的主要障碍。与传统塑胶不同，生物聚合物需要昂贵的原料、复杂的加工流程和大量的研发投入，这限制了其竞争力。扩大生产规模仍然困难重重，而高能耗的生产过程进一步推高了成本。对价格敏感的产业，例如消费品和包装产业，不愿采用这些材料。除非生产技术取得进步，降低成本并提高效率，否则生物聚合物的应用将受到限制，即使对永续替代品的需求持续成长，市场成长也将受到抑制。

医疗和生物医学领域的成长

在医疗领域，具有生物相容性和环境安全性的生物聚合物展现出巨大的成长潜力。其应用包括药物递送控制、组织支架、创伤治疗和植入。聚合物设计的创新使得标靶治疗和个人化医疗解决方案成为可能。对永续医疗材料日益增长的需求正在催生新的商机。生物技术公司与聚合物研究人员之间的合作正在拓展其潜在应用。随着全球医疗保健支出不断增长以及先进医疗技术的日益普及，生物聚合物将在提供创新、安全且环保的医疗解决方案方面发挥关键作用。

与传统塑胶的竞争

由于传统塑胶具有成本效益高、供应充足和性能稳定等优势，它们对生物聚合物构成了重大挑战。习惯使用合成聚合物的产业可能会因为生物聚合物较高的製造成本和有限的规模化生产能力而犹豫是否转向使用。对成本敏感的产业，例如包装和消费品产业，往往更倾向于选择价格较低的材料。现有的传统塑胶製造、分销和回收基础设施进一步巩固了其强大的市场地位。除非生物聚合物能够达到与传统塑胶相当的价格和功能可靠性，否则它们将继续面临激烈的竞争，从而阻碍其普及应用并抑制整体市场成长。

新冠疫情的影响：

新冠疫情对生物聚合物市场既有限制性影响，也有刺激性影响。供应链中断、原材料短缺和暂时性停产最初导致营运放缓，产品上市延迟。另一方面，疫情也增加了对环保包装、医疗设备、个人防护工具（PPE）和一次性医疗产品的需求，从而促进了生物聚合物的应用。尤其是在医疗和製药领域，生物聚合物在医疗设备、植入和药物传输解决方案的应用显着加速。儘管初期面临许多困难，但疫情凸显了对永续和安全材料的需求，最终强化了生物聚合物的战略重要性，并改善了其长期市场前景。

在预测期内，聚乳酸（PLA）细分市场预计将占据最大的市场份额。

由于聚乳酸（PLA）供应充足、价格适中且应用广泛，涵盖包装、纺织品、医疗和一次性用品等领域，预计在预测期内，PLA将占据最大的市场份额。 PLA源自玉米淀粉和甘蔗等可再生资源，是一种可生物降解且环境友善的材料。其优异的机械性能、易于加工以及与现有生产系统的兼容性使其具有很高的应用价值。消费者环保意识的增强和政府的支持政策进一步推动了对PLA的需求。因此，PLA保持着最大的市场份额，并已成为永续创新和全球生物聚合物产业的关键材料。

在预测期内，微生物领域预计将呈现最高的复合年增长率。

在预测期内，微生物衍生生物聚合物预计将呈现最高的成长率。这些生物聚合物由细菌、酵母或真菌发酵生产，具有品质稳定、纯度高、性能可调等优点，使其适用于生物医学、包装和医疗保健等领域。发酵技术、製程优化和基因工程的进步正在提高产量、降低生产成本并拓展工业应用。加之市场对永续、可生物降解和高性能材料的需求不断增长，以及持续的研发投入，微生物衍生生物聚合物正引领全球生物聚合物市场成长，成为成长最快的品类。

市占率最大的地区：

在整个预测期内，北美预计将保持最大的市场份额，这主要得益于其强大的工业基础、技术进步以及对永续材料的坚定承诺。积极的研究、有利的法规以及消费者对环保产品日益增长的需求，正在巩固其市场领导地位。该地区拥有许多知名的生物聚合物生产商和完善的供应链网络。生物聚合物在包装、医疗保健、汽车和电子等行业的生产应用正在迅速扩展。持续的创新、对先进生物聚合物解决方案的投资以及对生态系统永续永续性的坚定承诺，将使北美能够保持其领先地位，并继续引领全球生物聚合物应用市场。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于工业扩张、人口增长以及对永续解决方案日益增长的需求。政府对环保替代方案的支持以及不断增强的环保意识是关键的成长要素。中国、印度和日本等国家正大力投资研发、生产设施和可再生原料。生物聚合物在亚太地区的包装、医疗、汽车和纺织业的应用日益广泛。技术进步、生产效率的提高以及策略联盟的建立，共同推动了市场的快速发展，使亚太地区成为全球生物聚合物市场成长最快的地区。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章：执行摘要

  • 市场概览及主要亮点
  • 驱动因素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球生物聚合物创新市场：依聚合物类型划分

  • 聚乳酸（PLA）
  • 聚羟基烷酯（PHA）
  • 淀粉基生物聚合物
  • 纤维素基生物聚合物
  • 蛋白质衍生的生物聚合物
  • 新兴生物聚合物

第六章 全球生物聚合物创新市场：依来源划分

  • 植物来源原料
  • 微生物来源
  • 海洋来源
  • 源自废弃物

第七章 全球生物聚合物创新市场：依应用领域划分

  • 包装
  • 农业
  • 医疗保健
  • 消费品（包装除外）
  • 汽车和电子
  • 建筑材料

第八章 全球生物聚合物创新市场：按地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第九章 战略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十章：产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十一章：公司简介

  • NatureWorks
  • BASF
  • Corbion
  • Mitsubishi Chemical Corporation
  • Novamont
  • Danisco（DuPont Nutrition & Biosciences）
  • Braskem
  • Biome Bioplastics
  • Arkema
  • Synbra Technology
  • Ticona（Celanese）
  • Futerro
  • Plantic Technologies
  • Avantium
  • DIC Corporation
  • Sulapac
  • Danimer Scientific
  • BIOTEC
Product Code: SMRC34298

According to Stratistics MRC, the Global Biopolymer Innovation Market is accounted for $2.6 billion in 2026 and is expected to reach $6.5 billion by 2034 growing at a CAGR of 12.0% during the forecast period. The field of biopolymer innovation is reshaping multiple sectors by creating eco-friendly substitutes for traditional plastics. Scientists are producing high-performance biopolymers from renewable sources like plants, algae, and microbes, ensuring biodegradability and minimal environmental impact. These materials are being adopted in packaging, healthcare, textiles, and automotive industries to cut fossil fuel use and carbon emissions. Efforts emphasize enhancing strength, heat resistance, and versatility to satisfy industrial standards. Moreover, biopolymers are being designed for advanced applications, including controlled drug release and adaptive materials, promoting both environmental responsibility and technological progress across various markets.

According to the European Bioplastics Association, global production capacity for bioplastics (which includes biopolymers such as PLA, PHA, starch blends, and bio-based PET) is projected to increase from around 2.2 million tonnes in 2022 to approximately 6.3 million tonnes by 2027, driven largely by packaging and consumer goods demand.

Market Dynamics:

Driver:

Rising demand in packaging industry

The growing trend toward green packaging is a major market driver for biopolymers. Consumers seek biodegradable and renewable packaging options to minimize environmental harm. Biopolymers are increasingly used in food containers, bottles, and wraps due to compostability and protection of contents. Companies invest in durable, cost-effective biopolymers with strong barrier properties. Policy regulations and corporate sustainability goals support the adoption of eco-friendly packaging solutions. The packaging sector's emphasis on environmentally responsible materials is fueling the biopolymer innovation market, positioning it as a key factor in global growth and widespread industrial application.

Restraint:

High production costs

The elevated costs associated with biopolymer production act as a key barrier to market growth. Unlike traditional plastics, biopolymers demand costly raw materials, advanced processing methods, and significant research investment, limiting competitiveness. Scaling up production remains challenging, and energy-intensive manufacturing processes further increase expenses. Price-sensitive sectors, such as consumer goods and packaging, hesitate to adopt these materials. Unless production technologies advance to reduce costs and enhance efficiency, the broader acceptance of biopolymers will be constrained, restraining market growth even as demand for sustainable alternatives continues to rise.

Opportunity:

Growth in healthcare and biomedical applications

The healthcare sector offers substantial growth prospects for biopolymers due to their compatibility with the human body and environmentally safe characteristics. Applications include controlled drug delivery, tissue scaffolding, wound healing, and implants. Innovations in polymer design allow targeted treatments and personalized healthcare solutions. Rising demand for sustainable medical materials opens new business opportunities. Partnerships between biotech companies and polymer researchers are expanding potential uses. As global healthcare spending increases and advanced medical technologies gain traction, biopolymers can play a crucial role in delivering innovative, safe, and eco-friendly healthcare solutions.

Threat:

Competition from conventional plastics

Traditional plastics remain a major challenge for biopolymers due to their cost-effectiveness, widespread availability, and consistent performance. Industries familiar with synthetic polymers may hesitate to switch because of higher production costs and limited scalability of biopolymers. Cost-conscious sectors, like packaging and consumer products, often prefer cheaper materials. Existing infrastructure for manufacturing, distributing, and recycling conventional plastics reinforces their market stronghold. Unless biopolymers achieve comparable affordability and functional reliability, they will continue facing stiff competition, hindering widespread adoption and restraining overall market growth.

Covid-19 Impact:

The Covid-19 outbreak had both constraining and stimulating effects on the biopolymer market. Supply chain interruptions, limited raw materials, and temporary production shutdowns initially slowed operations and postponed product introductions. Conversely, the crisis increased demand for eco-friendly packaging, medical equipment, PPE, and disposable healthcare products, driving biopolymer adoption. The medical and pharmaceutical sectors notably accelerated usage in devices, implants, and drug delivery solutions. Despite early setbacks, the pandemic underscored the necessity for sustainable and safe materials, ultimately reinforcing the strategic importance of biopolymers and enhancing their long-term market prospects.

The polylactic acid (PLA) segment is expected to be the largest during the forecast period

The polylactic acid (PLA) segment is expected to account for the largest market share during the forecast period due to its abundant availability, affordability, and broad industrial applications, including packaging, textiles, healthcare, and disposable products. Sourced from renewable materials like corn starch and sugarcane, PLA is biodegradable and eco-friendly. Its strong mechanical characteristics, ease of processing, and compatibility with existing production systems make it highly adoptable. Rising environmental awareness among consumers and supportive government policies further drive PLA demand. As a result, PLA maintains the largest market share, establishing itself as a cornerstone for sustainable innovation and a key material in the global biopolymer industry.

The microbial-derived segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the microbial-derived segment is predicted to witness the highest growth rate. Produced via bacterial, yeast, or fungal fermentation, these biopolymers provide consistent quality, high purity, and tunable properties suitable for biomedical, packaging, and healthcare applications. Advances in fermentation technology, process optimization, and genetic engineering are enhancing yields, lowering production costs, and broadening industrial use. Rising demand for sustainable, biodegradable, and high-performance materials, coupled with continuous research and development efforts, is propelling the microbial-derived segment as the highest growth rate contributor and the most rapidly expanding category in the global biopolymer market.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, driven by a robust industrial framework, technological advancements, and a strong preference for sustainable materials. Active research, supportive regulations, and growing consumer demand for environmentally friendly products reinforce market leadership. The region hosts prominent biopolymer manufacturers and well-established supply networks. Industries like packaging, healthcare, automotive, and electronics are increasingly utilizing biopolymers in production. Persistent innovation, investment in advanced biopolymer solutions, and emphasis on ecological sustainability enable North America to maintain its top position and lead the global market in biopolymer adoption.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by industrial expansion, rising population, and increased demand for sustainable solutions. Government support for eco-friendly alternatives and growing environmental awareness are key growth factors. Countries including China, India, and Japan are heavily investing in R&D, production facilities, and renewable feedstocks. The region's packaging, healthcare, automotive, and textile industries are increasingly adopting biopolymers. Advancements in technology, improved production efficiency, and strategic collaborations contribute to rapid market development, positioning Asia-Pacific as the region with the highest growth rate in the global biopolymer market.

Key players in the market

Some of the key players in Biopolymer Innovation Market include NatureWorks, BASF, Corbion, Mitsubishi Chemical Corporation, Novamont, Danisco (DuPont Nutrition & Biosciences), Braskem, Biome Bioplastics, Arkema, Synbra Technology, Ticona (Celanese), Futerro, Plantic Technologies, Avantium, DIC Corporation, Sulapac, Danimer Scientific and BIOTEC.

Key Developments:

In February 2026, DIC Corporation announced that it has established a $62 million investment portfolio to accelerate business creation in the rapidly expanding Physical AI domain, which includes technologies such as sensors, wearables, robotics and automation. As part of this initiative, DIC has entered into a strategic partnership with Emerald Technology Ventures, a Switzerland-based global venture capital firm known for its deep expertise in industrial technologies and strong presence across Europe and North America.

In October 2025, BASF SE and ANDRITZ Group have signed a license agreement for the use of BASF's proprietary gas treatment technology, OASE(R) blue, in a carbon capture project planned to be implemented in the city of Aarhus, Denmark. The project aims to capture approximately 435,000 tons of CO2 annually from the flue gases of a waste-to-energy plant for sequestration; the city of Aarhus has set itself the goal of becoming CO2-neutral by 2030.

In September 2025, Mitsubishi Chemical Corporation has officially announced that it has entered into an Agreement on Coordination and Cooperation for the Maintenance and Development of the Yokkaichi Industrial Complex. This agreement, involves three parties-Mitsubishi Chemical, Mie Prefecture, and Yokkaichi City.

Polymer Types Covered:

  • Polylactic Acid (PLA)
  • Polyhydroxyalkanoates (PHA)
  • Starch-Based Biopolymers
  • Cellulose-Based Biopolymers
  • Protein-Based Biopolymers
  • Emerging Biopolymers

Sources Covered:

  • Plant-Based Feedstock
  • Microbial-Derived
  • Marine-Derived
  • Waste-Derived

Applications Covered:

  • Packaging
  • Agriculture
  • Medical & Healthcare
  • Consumer Goods (Non-Packaging)
  • Automotive & Electronics
  • Construction & Building Materials

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biopolymer Innovation Market, By Polymer Type

  • 5.1 Polylactic Acid (PLA)
  • 5.2 Polyhydroxyalkanoates (PHA)
  • 5.3 Starch-Based Biopolymers
  • 5.4 Cellulose-Based Biopolymers
  • 5.5 Protein-Based Biopolymers
  • 5.6 Emerging Biopolymers

6 Global Biopolymer Innovation Market, By Source

  • 6.1 Plant-Based Feedstock
  • 6.2 Microbial-Derived
  • 6.3 Marine-Derived
  • 6.4 Waste-Derived

7 Global Biopolymer Innovation Market, By Application

  • 7.1 Packaging
  • 7.2 Agriculture
  • 7.3 Medical & Healthcare
  • 7.4 Consumer Goods (Non-Packaging)
  • 7.5 Automotive & Electronics
  • 7.6 Construction & Building Materials

8 Global Biopolymer Innovation Market, By Geography

  • 8.1 North America
    • 8.1.1 United States
    • 8.1.2 Canada
    • 8.1.3 Mexico
  • 8.2 Europe
    • 8.2.1 United Kingdom
    • 8.2.2 Germany
    • 8.2.3 France
    • 8.2.4 Italy
    • 8.2.5 Spain
    • 8.2.6 Netherlands
    • 8.2.7 Belgium
    • 8.2.8 Sweden
    • 8.2.9 Switzerland
    • 8.2.10 Poland
    • 8.2.11 Rest of Europe
  • 8.3 Asia Pacific
    • 8.3.1 China
    • 8.3.2 Japan
    • 8.3.3 India
    • 8.3.4 South Korea
    • 8.3.5 Australia
    • 8.3.6 Indonesia
    • 8.3.7 Thailand
    • 8.3.8 Malaysia
    • 8.3.9 Singapore
    • 8.3.10 Vietnam
    • 8.3.11 Rest of Asia Pacific
  • 8.4 South America
    • 8.4.1 Brazil
    • 8.4.2 Argentina
    • 8.4.3 Colombia
    • 8.4.4 Chile
    • 8.4.5 Peru
    • 8.4.6 Rest of South America
  • 8.5 Rest of the World (RoW)
    • 8.5.1 Middle East
      • 8.5.1.1 Saudi Arabia
      • 8.5.1.2 United Arab Emirates
      • 8.5.1.3 Qatar
      • 8.5.1.4 Israel
      • 8.5.1.5 Rest of Middle East
    • 8.5.2 Africa
      • 8.5.2.1 South Africa
      • 8.5.2.2 Egypt
      • 8.5.2.3 Morocco
      • 8.5.2.4 Rest of Africa

9 Strategic Market Intelligence

  • 9.1 Industry Value Network and Supply Chain Assessment
  • 9.2 White-Space and Opportunity Mapping
  • 9.3 Product Evolution and Market Life Cycle Analysis
  • 9.4 Channel, Distributor, and Go-to-Market Assessment

10 Industry Developments and Strategic Initiatives

  • 10.1 Mergers and Acquisitions
  • 10.2 Partnerships, Alliances, and Joint Ventures
  • 10.3 New Product Launches and Certifications
  • 10.4 Capacity Expansion and Investments
  • 10.5 Other Strategic Initiatives

11 Company Profiles

  • 11.1 NatureWorks
  • 11.2 BASF
  • 11.3 Corbion
  • 11.4 Mitsubishi Chemical Corporation
  • 11.5 Novamont
  • 11.6 Danisco (DuPont Nutrition & Biosciences)
  • 11.7 Braskem
  • 11.8 Biome Bioplastics
  • 11.9 Arkema
  • 11.10 Synbra Technology
  • 11.11 Ticona (Celanese)
  • 11.12 Futerro
  • 11.13 Plantic Technologies
  • 11.14 Avantium
  • 11.15 DIC Corporation
  • 11.16 Sulapac
  • 11.17 Danimer Scientific
  • 11.18 BIOTEC

List of Tables

  • Table 1 Global Biopolymer Innovation Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biopolymer Innovation Market Outlook, By Polymer Type (2023-2034) ($MN)
  • Table 3 Global Biopolymer Innovation Market Outlook, By Polylactic Acid (PLA) (2023-2034) ($MN)
  • Table 4 Global Biopolymer Innovation Market Outlook, By Polyhydroxyalkanoates (PHA) (2023-2034) ($MN)
  • Table 5 Global Biopolymer Innovation Market Outlook, By Starch-Based Biopolymers (2023-2034) ($MN)
  • Table 6 Global Biopolymer Innovation Market Outlook, By Cellulose-Based Biopolymers (2023-2034) ($MN)
  • Table 7 Global Biopolymer Innovation Market Outlook, By Protein-Based Biopolymers (2023-2034) ($MN)
  • Table 8 Global Biopolymer Innovation Market Outlook, By Emerging Biopolymers (2023-2034) ($MN)
  • Table 9 Global Biopolymer Innovation Market Outlook, By Source (2023-2034) ($MN)
  • Table 10 Global Biopolymer Innovation Market Outlook, By Plant-Based Feedstock (2023-2034) ($MN)
  • Table 11 Global Biopolymer Innovation Market Outlook, By Microbial-Derived (2023-2034) ($MN)
  • Table 12 Global Biopolymer Innovation Market Outlook, By Marine-Derived (2023-2034) ($MN)
  • Table 13 Global Biopolymer Innovation Market Outlook, By Waste-Derived (2023-2034) ($MN)
  • Table 14 Global Biopolymer Innovation Market Outlook, By Application (2023-2034) ($MN)
  • Table 15 Global Biopolymer Innovation Market Outlook, By Packaging (2023-2034) ($MN)
  • Table 16 Global Biopolymer Innovation Market Outlook, By Agriculture (2023-2034) ($MN)
  • Table 17 Global Biopolymer Innovation Market Outlook, By Medical & Healthcare (2023-2034) ($MN)
  • Table 18 Global Biopolymer Innovation Market Outlook, By Consumer Goods (Non-Packaging) (2023-2034) ($MN)
  • Table 19 Global Biopolymer Innovation Market Outlook, By Automotive & Electronics (2023-2034) ($MN)
  • Table 20 Global Biopolymer Innovation Market Outlook, By Construction & Building Materials (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.